Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ffipsc197_promoter_p_PM_12_138_9			2	0.4	5.40E-04	PCDHA5, PCDHA9, PLCG2, TPI1, PCDHA10, PCDHA6	homophilic cell adhesion [BP], follicular B cell differentiation [BP], calcium ion binding [MF], triose-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_16_34_21			4	0.8	6.29E-05	CCP110, PLK4	centriole replication [BP]
CG_ffipsc197_promoter_p_PM_12_197_10			3	0.6	3.02E-04	FGFR4, TDRD5, TAS1R3	P granule organization [BP], detection of chemical stimulus involved in sensory perception of sweet taste [BP], alveolar secondary septum development [BP], sweet taste receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_117_7			3	0.6	4.83E-04	HSD11B1, EXT2	heparan sulfate N-acetylglucosaminyltransferase activity [MF], N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [MF], 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF], 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [MF]
CG_ffipsc197_promoter_p_PM_18_28_38			4	0.8	4.17E-05	MAPK14, JUNB, NOP58, NUDT16L1, TRNP1	snoRNA binding [MF], osteoclast differentiation [BP], cell cycle [BP]
CG_ffipsc197_promoter_p_PM_14_8_27			10	1.0	3.31E-05	PAAF1, CDC20, NDUFS7, PSMD9, PSMB4, NARF	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], quinone binding [MF], proteasome complex [CC], positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], nuclear lumen [CC]
CG_ffipsc197_promoter_p_PM_12_329_8			2	0.4	3.88E-04	F2, CREB3, FATE1, SPCS3, DOLPP1	positive regulation of calcium ion transport [BP], positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], dolichyldiphosphatase activity [MF], endoplasmic reticulum [CC], negative regulation of ligand-dependent nuclear receptor transcription coactivator activity [BP]
CG_ffipsc197_promoter_p_PM_12_95_20			4	0.8	7.29E-05	DLK1, DYNLL2, CHST11	N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [MF], post-embryonic development [BP], embryonic skeletal system development [BP], synaptic target recognition [BP], chondroitin 4-sulfotransferase activity [MF], polysaccharide localization [BP]
CG_ffipsc197_promoter_p_PM_12_65_7			2	0.4	1.20E-04	AKAP13	regulation of glucocorticoid mediated signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_263_10			3	0.6	1.30E-04	TPI1	glyceraldehyde-3-phosphate metabolic process [BP], triose-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_248_7			2	0.4	1.19E-04	CLIC4, KATNB1, IL6	interleukin-6 receptor complex [CC], hepatic immune response [BP], response to calcium ion [BP], midbody [CC], katanin complex [CC], negative regulation of chemokine biosynthetic process [BP], negative regulation of collagen biosynthetic process [BP], positive regulation of STAT protein import into nucleus [BP], positive regulation of microtubule depolymerization [BP]
CG_ffipsc197_promoter_p_PM_18_32_32			3	0.6	5.45E-05	LRTOMT, NAALAD2	neurotransmitter catabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_61_11			1	0.2	6.01E-05	PIM3	negative regulation of insulin secretion involved in cellular response to glucose stimulus [BP]
CG_ffipsc197_promoter_p_PM_12_233_10			4	0.6	7.57E-06	PRMT1	histone methyltransferase activity (H4-R3 specific) [MF], snoRNP binding [MF], [cytochrome c]-arginine N-methyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_16_42_10			4	0.8	4.30E-05	GSG2	mitotic sister chromatid cohesion [BP]
CG_ffipsc197_promoter_p_PM_12_228_8			1	0.2	2.72E-04	ALPI, POMT1	alkaline phosphatase activity [MF], dolichyl-phosphate-mannose-protein mannosyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_265_14			2	0.4	2.60E-04	ASPSCR1	extrinsic to membrane [CC], internal side of plasma membrane [CC]
CG_ffipsc197_promoter_p_PM_12_292_9			1	0.2	2.07E-04	CD3EAP, ACE, ARHGEF10	positive regulation of GTP catabolic process [BP], peptidyl-dipeptidase activity [MF], RNA polymerase I transcription factor complex [CC], bradykinin receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_111_8			1	0.2	1.43E-04	SLC5A3	myo-inositol:sodium symporter activity [MF]
CG_ffipsc197_promoter_p_PM_16_24_19			4	0.8	3.94E-05	IL13, CD40, ADIPOQ, NASP	positive regulation of B cell proliferation [BP], cell proliferation [BP], positive regulation of peptidyl-tyrosine phosphorylation [BP]
CG_ffipsc197_promoter_p_PM_14_77_13			4	0.8	8.99E-05	ABHD6	regulation of endocannabinoid signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_225_12			3	0.6	1.52E-04	RPIA, CLDN10, CLDN16, ST6GAL1, CARTPT	calcium-independent cell-cell adhesion [BP], beta-galactoside alpha-2,6-sialyltransferase activity [MF], positive regulation of epinephrine secretion [BP], ribose-5-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_35_12			2	0.4	7.91E-05	DUT	dUTP diphosphatase activity [MF], dUMP biosynthetic process [BP]
CG_ffipsc197_promoter_p_PM_14_28_15			2	0.4	1.76E-05	STRA8, BMPR1A	female meiosis sister chromatid cohesion [BP], neural plate mediolateral regionalization [BP], regulation of lateral mesodermal cell fate specification [BP], meiotic DNA double-strand break formation [BP], meiotic cell cycle DNA replication checkpoint [BP], paraxial mesoderm structural organization [BP]
CG_ffipsc197_promoter_p_PM_14_53_9			1	0.2	2.24E-05	WRAP53	telomere formation via telomerase [BP]
CG_ffipsc197_promoter_p_PM_12_163_13			3	0.6	2.86E-04	LFNG	O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_18_27_5			2	0.4	1.90E-05	UMPS, SGMS2	orotate phosphoribosyltransferase activity [MF], integral to cell outer membrane [CC], orotidine-5'-phosphate decarboxylase activity [MF]
CG_ffipsc197_promoter_p_PM_12_226_7			2	0.4	6.06E-05	CBX3, SUPT6H	nuclear centromeric heterochromatin [CC], chromatin remodeling [BP]
CG_ffipsc197_promoter_p_PM_12_108_5			3	0.6	2.24E-04	CDK14	cytoplasmic cyclin-dependent protein kinase holoenzyme complex [CC]
CG_ffipsc197_promoter_p_PM_12_296_4			2	0.4	4.36E-05	FDFT1, NQO2, PPP1R3G	farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF], dihydronicotinamide riboside quinone reductase activity [MF], NADPH dehydrogenase (quinone) activity [MF], glycogen binding [MF]
CG_ffipsc197_promoter_p_PM_18_15_11			4	0.8	5.52E-05	TRAF2, D2HGDH, BIRC2, CDC42, MARCH5	protein autoubiquitination [BP], CD40 receptor complex [CC], protein polyubiquitination [BP], NIK/NF-kappaB cascade [BP], thioesterase binding [MF], actin filament branching [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_14_51_16			5	1.0	3.99E-05	KIF19	plus-end specific microtubule depolymerization [BP], axonemal microtubule depolymerization [BP]
CG_ffipsc197_promoter_p_PM_14_58_19			2	0.4	3.79E-05	NAGS	acetyl-CoA:L-glutamate N-acetyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_146_7			2	0.4	7.68E-05	ACTN4, LRWD1	establishment of protein localization to chromatin [BP], positive regulation of pinocytosis [BP]
CG_ffipsc197_promoter_p_PM_14_36_14			2	0.4	2.02E-05	SLC50A1, APAF1, KPNB1	glucoside transmembrane transporter activity [MF], apoptotic DNA fragmentation [BP]
CG_ffipsc197_promoter_p_PM_12_80_8			2	0.4	6.72E-05	AMDHD2, PRKCG, ASXL1	PR-DUB complex [CC], positive regulation of mismatch repair [BP], N-acetylglucosamine-6-phosphate deacetylase activity [MF]
CG_ffipsc197_promoter_p_PM_14_76_7			1	0.2	2.94E-05	DNAJA3, SULT1C3	interferon-gamma receptor binding [MF], alcohol sulfotransferase activity [MF], actin filament [CC]
CG_ffipsc197_promoter_p_PM_12_174_16			4	0.8	2.78E-05	CHRD, ST3GAL4, CHAT, ASL, HIF1AN	arginine biosynthetic process via ornithine [BP], argininosuccinate lyase activity [MF], monosialoganglioside sialyltransferase activity [MF], peptidyl-histidine hydroxylation [BP], peptidyl-histidine dioxygenase activity [MF], BMP signaling pathway involved in spinal cord dorsal/ventral patterning [BP], peptidyl-asparagine 3-dioxygenase activity [MF], choline O-acetyltransferase activity [MF], peptidyl-asparagine hydroxylation [BP]
CG_ffipsc197_promoter_p_PM_12_170_9			1	0.2	3.28E-05	MARCKS, NADSYN1, CCDC64	NAD+ synthase (glutamine-hydrolyzing) activity [MF], germinal vesicle [CC], Golgi to secretory granule transport [BP]
CG_ffipsc197_promoter_p_PM_12_222_7			2	0.4	9.61E-05	E2F3, KIT, CDK1	activation of MAPK activity [BP], pronuclear fusion [BP], erythropoietin-mediated signaling pathway [BP], regulation of Schwann cell differentiation [BP], melanocyte migration [BP], Kit signaling pathway [BP], Fc receptor signaling pathway [BP], positive regulation of cell proliferation [BP], stem cell factor receptor activity [MF], melanocyte adhesion [BP]
CG_ffipsc197_promoter_p_PM_18_33_30			4	0.8	5.47E-05	SEC23B, SEC24C	COPII vesicle coat [CC]
CG_ffipsc197_promoter_p_PM_12_264_16			3	0.6	4.41E-05	THTPA, NIT2, CDK1	thiamin-triphosphatase activity [MF], pronuclear fusion [BP], omega-amidase activity [MF]
CG_ffipsc197_promoter_p_PM_12_311_10			2	0.4	3.64E-05	NCOA1, INMT, CAV1, CD4	induction by virus of host cell-cell fusion [BP], amine N-methyltransferase activity [MF], positive regulation of transcription from RNA polymerase II promoter by galactose [BP], thioether S-methyltransferase activity [MF], T cell costimulation [BP], protein palmitoleylation [BP]
CG_ffipsc197_promoter_p_PM_12_271_6			2	0.4	4.37E-05	SLC25A37	mitochondrial iron ion transport [BP]
CG_ffipsc197_promoter_p_PM_14_75_11			1	0.2	3.01E-05	FOXB1, KPNA2, AKAP13, SNX2	cell migration in diencephalon [BP], hypothalamus cell migration [BP], protein transporter activity [MF], M phase specific microtubule process [BP], mammillary body development [BP], regulation of glucocorticoid mediated signaling pathway [BP], inferior colliculus development [BP], mammillothalamic axonal tract development [BP]
CG_ffipsc197_promoter_p_PM_14_27_6			2	0.4	2.16E-05	SLC26A11, ARHGEF10L, ARHGEF1, SLC26A10	sulfate transmembrane transporter activity [MF], antiporter activity [MF], sulfate transport [BP], Rho guanyl-nucleotide exchange factor activity [MF]
CG_ffipsc197_promoter_p_PM_12_151_12			1	0.2	4.71E-05	DYNLL2, CAMSAP3	synaptic target recognition [BP], microtubule minus-end binding [MF]
CG_ffipsc197_promoter_p_PM_16_20_7			2	0.4	6.23E-05	WNT1, OGG1, IRAK3	positive regulation of macrophage tolerance induction [BP], 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF], midbrain-hindbrain boundary maturation during brain development [BP], negative regulation of DNA damage checkpoint [BP], cerebellum formation [BP], oxidized purine nucleobase lesion DNA N-glycosylase activity [MF]
CG_ffipsc197_promoter_p_PM_12_254_7			2	0.4	4.35E-05	SLC5A5	sodium:iodide symporter activity [MF]
CG_ffipsc197_promoter_p_PM_12_313_11			3	0.6	3.20E-05	USP13, ALG1, SEC61B, CDK1, TRIM32	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], ubiquitin-dependent protein catabolic process [BP], protein import into nucleus, translocation [BP], ubiquitin binding [MF], pronuclear fusion [BP]
CG_ffipsc197_promoter_p_PM_12_89_6			2	0.4	3.05E-06	ERBB2IP, PTGR2, SKI	basal protein localization [BP], histone deacetylase inhibitor activity [MF], 15-oxoprostaglandin 13-oxidase activity [MF], 13-prostaglandin reductase activity [MF]
CG_ffipsc197_promoter_p_PM_12_282_7			1	0.2	1.62E-04	AP2A2, CLEC4M	endocytosis [BP]
CG_ffipsc197_promoter_p_PM_12_200_10			2	0.4	1.69E-04	PCBD2, ARHGEF10	positive regulation of GTP catabolic process [BP], 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [MF]
CG_ffipsc197_promoter_p_PM_12_199_11			2	0.4	3.55E-05	DLK1, LRWD1, CD5	establishment of protein localization to chromatin [BP], telomeric heterochromatin [CC], external side of plasma membrane [CC]
CG_ffipsc197_promoter_p_PM_16_33_28			4	0.8	1.78E-04	MGAT2, SRGN	maintenance of granzyme B location in T cell secretory granule [BP], T cell secretory granule organization [BP], alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], maintenance of protease location in mast cell secretory granule [BP]
CG_ffipsc197_promoter_p_PM_12_205_6			1	0.2	1.64E-04	RNASE2, RNASE3	pancreatic ribonuclease activity [MF]
CG_ffipsc197_promoter_p_PM_12_230_9			2	0.4	4.84E-05	ANKRD42, MTDH, GNMT, DIO3, LBP	glycine N-methyltransferase activity [MF], lipopolysaccharide-mediated signaling pathway [BP], positive regulation of respiratory burst involved in inflammatory response [BP], leukocyte chemotaxis involved in inflammatory response [BP], thyroxine 5-deiodinase activity [MF], NF-kappaB binding [MF]
CG_ffipsc197_promoter_p_PM_12_119_7			1	0.2	1.35E-04	CACNA1E, HSD3B7	cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF], regulation of somatostatin secretion [BP]
CG_ffipsc197_promoter_p_PM_12_322_11			2	0.4	5.85E-05	LAT2, SYNGR3	SH2 domain binding [MF]
CG_ffipsc197_promoter_p_PM_12_28_12			2	0.4	2.14E-04	IL17C, WFS1	neutrophil differentiation [BP], negative regulation of type B pancreatic cell apoptotic process [BP], polyubiquitinated misfolded protein transport [BP]
CG_ffipsc197_promoter_p_PM_12_298_7			1	0.2	2.68E-04	NLGN1, PPARD	linoleic acid binding [MF], cytoskeletal matrix organization at active zone [BP], positive regulation of synaptic vesicle exocytosis [BP], neurexin clustering [BP], positive regulation of synaptic vesicle endocytosis [BP]
CG_ffipsc197_promoter_p_PM_16_2_15			5	1.0	2.92E-05	ZRANB1, ID2, EVI5L, TBC1D15, SLC3A2	protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP], leucine import [BP], positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP], Rab GTPase activator activity [MF]
CG_ffipsc197_promoter_p_PM_12_37_13			1	0.2	9.71E-05	CD1C, AOX1	endogenous lipid antigen binding [MF], exogenous lipid antigen binding [MF], aldehyde oxidase activity [MF], xanthine dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_18_22_30			4	0.8	5.63E-05	CTNS, KHDRBS1	compound eye corneal lens development [BP], Grb2-Sos complex [CC]
CG_ffipsc197_promoter_p_PM_12_209_4			1	0.2	3.67E-04	TLK2, MSH2, KSR1, MYO7A, PIP5K1A, FARS2	oxidized purine DNA binding [MF], dinucleotide repeat insertion binding [MF], negative regulation of reciprocal meiotic recombination [BP], single thymine insertion binding [MF], double-strand/single-strand DNA junction binding [MF], ATP binding [MF]
CG_ffipsc197_promoter_p_PM_12_134_4			2	0.4	9.90E-05	ATP5S	hydrogen ion transmembrane transporter activity [MF]
CG_ffipsc197_promoter_p_PM_18_17_20			4	0.8	8.34E-05	LRRC17, RPLP1, HGS, RPS28, NF1, TAOK2, RPS8, MRPL37	negative regulation of osteoclast differentiation [BP], structural constituent of ribosome [MF], protein targeting to membrane [BP], ribosomal small subunit biogenesis [BP], intracellular protein transport [BP]
CG_ffipsc197_promoter_p_PM_14_64_16			3	0.6	3.38E-05	P2RY6	UDP-activated nucleotide receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_69_9			4	0.6	5.74E-05	GRM7	adenylate cyclase inhibitor activity [MF]
CG_ffipsc197_promoter_p_PM_14_62_19			3	0.6	3.26E-05	NAGS, SAFB	core promoter binding [MF], acetyl-CoA:L-glutamate N-acetyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_164_14			2	0.4	2.57E-04	CYP27A1	cholestanetriol 26-monooxygenase activity [MF], cholesterol 26-hydroxylase activity [MF]
CG_ffipsc197_promoter_p_PM_18_3_29			4	0.8	3.56E-05	UBE2B, SMARCA4, AIRE, RCC1	histone binding [MF], nuclear chromatin [CC], regulation of S phase of mitotic cell cycle [BP]
CG_ffipsc197_promoter_p_PM_12_240_8			2	0.4	5.84E-06	ATP2A1, MDH2, BHMT2	malate dehydrogenase (NADP+) activity [MF], relaxation of skeletal muscle [BP], positive regulation of fast-twitch skeletal muscle fiber contraction [BP], betaine-homocysteine S-methyltransferase activity [MF], elevation of endoplasmic reticulum calcium ion concentration [BP], maintenance of mitochondrion location [BP], L-malate dehydrogenase activity [MF], H zone [CC]
CG_ffipsc197_promoter_p_PM_12_139_6			3	0.6	2.54E-04	ASS1, GPI, PI4K2A, PINK1	host cell presynaptic membrane [CC], argininosuccinate synthase activity [MF], AP-3 adaptor complex binding [MF], methylglyoxal biosynthetic process [BP], glucose-6-phosphate isomerase activity [MF], basophil degranulation [BP], C3HC4-type RING finger domain binding [MF]
CG_ffipsc197_promoter_p_PM_16_22_14			4	0.8	6.93E-05	DMBT1	induction of bacterial agglutination [BP], zymogen binding [MF]
CG_ffipsc197_promoter_p_PM_12_98_13			2	0.4	1.75E-05	SPAST	cytokinesis, completion of separation [BP]
CG_ffipsc197_promoter_p_PM_14_17_5			1	0.2	2.76E-04	VASH1, SOX8	negative regulation of lymphangiogenesis [BP], retinal rod cell differentiation [BP], renal vesicle induction [BP]
CG_ffipsc197_promoter_p_PM_12_188_5			3	0.6	1.35E-04	PLCB1, TGFB2, HIF1AN, GLRB, SPPL2B, CADM3, RAB11FIP3	protein homodimerization activity [MF], positive regulation of myoblast differentiation [BP], acrosome reaction [BP]
CG_ffipsc197_promoter_p_PM_14_31_9			2	0.4	7.17E-05	BIRC5	interphase microtubule organizing center [CC]
CG_ffipsc197_promoter_p_PM_12_250_7			2	0.4	2.03E-05	EDN3	vein smooth muscle contraction [BP]
CG_ffipsc197_promoter_p_PM_12_90_6			2	0.4	1.17E-04	AASDHPPT	holo-[acyl-carrier-protein] synthase activity [MF]
CG_ffipsc197_promoter_p_PM_12_317_12			1	0.2	6.65E-05	TGFBR2, IRAK4, CREBRF	positive regulation of tolerance induction to self antigen [BP], bronchus morphogenesis [BP], type III transforming growth factor beta receptor binding [MF], positive regulation of smooth muscle cell proliferation [BP], negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_ffipsc197_promoter_p_PM_16_19_8			4	0.8	6.96E-05	GEMIN7, BCKDHA, MIXL1	SMN complex [CC], positive regulation of mesoderm development [BP], 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [MF], alpha-ketoacid dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_12_315_9			2	0.4	1.87E-04	DAO	D-alanine catabolic process [BP], D-serine catabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_211_7			2	0.4	1.03E-04	TPO	iodide peroxidase activity [MF]
CG_ffipsc197_promoter_p_PM_12_145_12			2	0.4	6.67E-05	VANGL2	establishment of body hair planar orientation [BP], orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [BP], lateral sprouting involved in lung morphogenesis [BP], planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [BP]
CG_ffipsc197_promoter_p_PM_12_46_11			3	0.6	4.81E-05	MPV17L	negative regulation of hydrogen peroxide biosynthetic process [BP]
CG_ffipsc197_promoter_p_PM_12_45_7			2	0.4	2.43E-04	VDAC3	adenine transport [BP], voltage-gated anion channel activity [MF]
CG_ffipsc197_promoter_p_PM_12_93_6			2	0.4	6.62E-06	STAG3, ASXL1	transverse filament [CC], monoubiquitinated histone H2A deubiquitination [BP], PR-DUB complex [CC], negative regulation of peroxisome proliferator activated receptor signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_17_11			4	0.8	3.37E-05	ACTR3, RHOB	cell cycle cytokinesis [BP], spindle localization [BP]
CG_ffipsc197_promoter_p_PM_14_16_11			3	0.6	5.43E-05	DDX3X, SGIP1, EDDM3A	positive regulation of feeding behavior [BP], sperm displacement [BP], RNA secondary structure unwinding [BP]
CG_ffipsc197_promoter_p_PM_12_196_6			1	0.2	1.91E-04	SNX1, DYNLL2, ABCD1	peroxisomal long-chain fatty acid import [BP], synaptic target recognition [BP], early endosome to Golgi transport [BP], peroxisomal fatty-acyl-CoA transporter activity [MF]
CG_ffipsc197_promoter_p_PM_12_125_7			2	0.4	1.49E-04	D2HGDH, SMARCB1, SETMAR, KMO	positive regulation of double-strand break repair via nonhomologous end joining [BP], DNA integration [BP], kynurenine 3-monooxygenase activity [MF], flavin adenine dinucleotide binding [MF], (R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_12_161_25			3	0.6	3.20E-05	ARHGAP42, NCK2	cytoskeletal adaptor activity [MF]
CG_ffipsc197_promoter_p_PM_16_29_15			4	0.8	9.51E-05	BCL3	marginal zone B cell differentiation [BP], follicular dendritic cell differentiation [BP], positive regulation of interleukin-10 biosynthetic process [BP], Bcl3/NF-kappaB2 complex [CC], Bcl3-Bcl10 complex [CC]
CG_ffipsc197_promoter_p_PM_12_12_8			1	0.2	2.64E-04	CYR61, MYL4	myosin II heavy chain binding [MF], intussusceptive angiogenesis [BP], positive regulation of ceramide biosynthetic process [BP], apoptotic process involved in heart morphogenesis [BP]
CG_ffipsc197_promoter_p_PM_18_18_17			2	0.4	4.69E-05	ST14, USP8	extrinsic to plasma membrane [CC]
CG_ffipsc197_promoter_p_PM_12_214_11			1	0.2	5.15E-05	DCSTAMP, BCO2, PRKAR2B	carotenoid metabolic process [BP], response to antipsychotic drug [BP], osteoclast fusion [BP], carotene catabolic process [BP], carotene metabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_223_10			3	0.6	4.81E-05	MLH1, BRE	response to DNA damage stimulus [BP], BRISC complex [CC], chiasma [CC], negative regulation of mitotic recombination [BP], guanine/thymine mispair binding [MF], spindle midzone assembly involved in meiosis [BP], meiotic metaphase I plate congression [BP], male meiosis chromosome segregation [BP], double-strand break repair [BP], MutLalpha complex [CC], MutLbeta complex [CC]
CG_ffipsc197_promoter_p_PM_12_122_5			2	0.4	4.81E-05	NANS, GALK2, CLYBL	N-acylneuraminate-9-phosphate synthase activity [MF], N-acetylgalactosamine kinase activity [MF], citrate (pro-3S)-lyase activity [MF], N-acetylneuraminate synthase activity [MF]
CG_ffipsc197_promoter_p_PM_12_132_4			1	0.2	1.66E-04	ALG1, AACS	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], acetoacetate-CoA ligase activity [MF]
CG_ffipsc197_promoter_p_PM_12_160_4			1	0.2	1.02E-04	LBP	leukocyte chemotaxis involved in inflammatory response [BP], lipopolysaccharide transport [BP], positive regulation of respiratory burst involved in inflammatory response [BP]
CG_ffipsc197_promoter_p_PM_12_153_10			2	0.4	6.82E-05	HPS6, GNA11, MAP2K1	developmental pigmentation [BP], receptor signaling protein tyrosine phosphatase activity [MF], protein tyrosine kinase activity [MF], melanocyte differentiation [BP]
CG_ffipsc197_promoter_p_PM_12_62_13			2	0.4	4.87E-04	GET4	BAT3 complex [CC]
CG_ffipsc197_promoter_p_PM_12_91_13			4	0.6	7.04E-05	YLPM1, ZFP90, TFAP2C	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF]
CG_ffipsc197_promoter_p_PM_14_81_19			12	1.0	3.07E-05	HAUS5	centrosome organization [BP]
CG_ffipsc197_promoter_p_PM_12_290_7			3	0.6	1.21E-04	ZFPM1, GRIN1	negative regulation of interleukin-4 biosynthetic process [BP], negative regulation of mast cell differentiation [BP], propylene metabolic process [BP]
CG_ffipsc197_promoter_p_PM_16_43_17			4	0.8	1.39E-04	ITGAV, BIRC7	negative regulation of entry of bacterium into host cell [BP], alphav-beta3 integrin-IGF-1-IGF1R complex [CC], entry of symbiont into host cell by promotion of host phagocytosis [BP], regulation of natural killer cell apoptotic process [BP]
CG_ffipsc197_promoter_p_PM_12_182_9			3	0.6	4.31E-06	INSIG1	SREBP-SCAP-Insig complex [CC], negative regulation of cargo loading into COPII-coated vesicle [BP]
CG_ffipsc197_promoter_p_PM_16_37_40			3	0.6	5.19E-05	VASH1	negative regulation of lymphangiogenesis [BP]
CG_ffipsc197_promoter_p_PM_14_35_11			4	0.8	6.08E-05	ERCC4, CLEC4M	nucleotide-excision repair factor 1 complex [CC], ICAM-3 receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_124_8			4	0.6	1.18E-04	HSD3B7	cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_12_100_11			2	0.4	6.43E-05	PHAX, SLC27A2	pristanate-CoA ligase activity [MF], phytanate-CoA ligase activity [MF], methyl-branched fatty acid metabolic process [BP], snRNA export from nucleus [BP]
CG_ffipsc197_promoter_p_PM_12_242_10			5	0.8	2.06E-04	AQP9, SLC22A3	histamine uptake [BP], pyrimidine nucleobase transport [BP]
CG_ffipsc197_promoter_p_PM_18_12_22			2	0.4	7.60E-05	MYCN, THRA, ATF5	negative regulation of astrocyte differentiation [BP], cartilage condensation [BP]
CG_ffipsc197_promoter_p_PM_12_247_8			2	0.4	3.23E-04	RGN, AMDHD2	N-acetylglucosamine-6-phosphate deacetylase activity [MF], gluconolactonase activity [MF]
CG_ffipsc197_promoter_p_PM_12_180_7			3	0.6	3.65E-05	ID4, MERTK, MYRF	oligodendrocyte development [BP], central nervous system myelination [BP], oligodendrocyte differentiation [BP], rhabdomere [CC]
CG_ffipsc197_promoter_p_PM_12_43_9			3	0.6	2.65E-04	MYO6, BIRC5	minus-end directed microfilament motor activity [MF], interphase microtubule organizing center [CC]
CG_ffipsc197_promoter_p_PM_12_114_9			2	0.4	1.04E-05	CREBRF	negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_ffipsc197_promoter_p_PM_12_131_13			1	0.2	8.63E-05	GRM2	group II metabotropic glutamate receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_176_9			2	0.4	2.44E-04	CHAF1A	CAF-1 complex [CC], DNA replication-dependent nucleosome assembly [BP]
CG_ffipsc197_promoter_p_PM_14_26_7			2	0.4	1.95E-05	PLEKHG6, RAB11A	cleavage furrow [CC]
CG_ffipsc197_promoter_p_PM_12_10_7			2	0.4	1.55E-04	CSF1	mammary gland fat development [BP], macrophage colony-stimulating factor receptor binding [MF]
CG_ffipsc197_promoter_p_PM_14_47_10			2	0.4	4.50E-05	FNTA, MTR	positive regulation of tubulin deacetylation [BP], methionine synthase activity [MF]
CG_ffipsc197_promoter_p_PM_12_238_10			2	0.4	7.42E-05	FNDC1, PRMT7, NFATC1	[myelin basic protein]-arginine N-methyltransferase activity [MF], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP], mitogen-activated protein kinase p38 binding [MF], histone methyltransferase activity (H4-R3 specific) [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], protein-arginine omega-N symmetric methyltransferase activity [MF], positive regulation of cardiac muscle cell apoptotic process [BP]
CG_ffipsc197_promoter_p_PM_12_278_7			1	0.2	2.57E-04	GPI, GTF2H3	core TFIIH complex [CC], methylglyoxal biosynthetic process [BP], glucose-6-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_84_7			2	0.4	3.81E-05	PSMC4, GCDH, GNAS, DNMT3B	genetic imprinting [BP], cellular nitrogen compound metabolic process [BP], DNA methylation [BP]
CG_ffipsc197_promoter_p_PM_12_50_5			1	0.2	7.50E-06	PKDCC, YWHAH	glucocorticoid catabolic process [BP], negative regulation of Golgi to plasma membrane protein transport [BP], negative regulation of dendrite morphogenesis [BP]
CG_ffipsc197_promoter_p_PM_14_7_6			2	0.4	6.74E-05	NLRP2	Pyrin domain binding [MF]
CG_ffipsc197_promoter_p_PM_14_80_12			2	0.4	3.83E-05	PRDX4, RBM3, PCK2	thioredoxin peroxidase activity [MF], ribosomal large subunit binding [MF], phosphoenolpyruvate carboxykinase activity [MF], phosphoenolpyruvate carboxykinase (GTP) activity [MF]
CG_ffipsc197_promoter_p_PM_16_14_12			4	0.8	1.37E-05	CFLAR, BLZF1, SAFB, RAI1, TFAP2C, ZNF205	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], regulation of transcription, DNA-dependent [BP], negative regulation of myoblast fusion [BP], positive regulation of mitochondrial outer membrane permeabilization [BP], growth [BP], positive regulation of hydrogen peroxide biosynthetic process [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_p_PM_12_195_8			3	0.4	3.05E-05	NKD1	eye photoreceptor cell differentiation [BP]
CG_ffipsc197_promoter_p_PM_12_328_15			3	0.6	9.14E-05	CHST3	proteoglycan sulfotransferase activity [MF], chondroitin 6-sulfotransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_224_14			1	0.2	9.80E-05	INPP5D, AMD1, CASQ1	S-adenosylmethioninamine biosynthetic process [BP], adenosylmethionine decarboxylase activity [MF], terminal cisterna lumen [CC], smooth endoplasmic reticulum [CC], negative regulation of neutrophil differentiation [BP]
CG_ffipsc197_promoter_p_PM_12_94_13			4	0.6	1.95E-04	HEXB, PIGL, NAA60, THNSL2, CAV1, GRIK2	lipid storage [BP], male courtship behavior [BP], 2-oxobutyrate biosynthetic process [BP], N-acetylglucosaminylphosphatidylinositol deacetylase activity [MF], calcium ion homeostasis [BP], acrosomal vesicle [CC], N-terminal peptidyl-methionine acetylation [BP], cellular calcium ion homeostasis [BP]
CG_ffipsc197_promoter_p_PM_12_333_11			3	0.6	4.30E-05	MOCOS	Mo-molybdopterin cofactor sulfurase activity [MF]
CG_ffipsc197_promoter_p_PM_12_184_8			5	0.8	1.45E-04	KLF2, BPI	negative regulation of interleukin-6 production [BP]
CG_ffipsc197_promoter_p_PM_12_135_6			1	0.2	2.06E-04	SERPINE1, GLP2R, CPSF4	negative regulation of smooth muscle cell-matrix adhesion [BP], negative regulation of vascular wound healing [BP], positive regulation of leukotriene production involved in inflammatory response [BP], chronological cell aging [BP], glucagon receptor activity [MF], modification by virus of host mRNA processing [BP]
CG_ffipsc197_promoter_p_PM_12_75_8			1	0.2	1.78E-04	MSH6	single guanine insertion binding [MF], oxidized purine DNA binding [MF], MutSalpha complex [CC], single thymine insertion binding [MF], guanine/thymine mispair binding [MF]
CG_ffipsc197_promoter_p_PM_12_52_7			2	0.4	1.09E-04	TIMP1, MYO6, KLF2	minus-end directed microfilament motor activity [MF], erythrocyte maturation [BP]
CG_ffipsc197_promoter_p_PM_12_171_19			2	0.4	3.09E-04	RGS14	negative regulation of synaptic plasticity [BP], positive regulation of neurogenesis [BP], zygote asymmetric cell division [BP]
CG_ffipsc197_promoter_p_PM_12_262_5			1	0.2	2.18E-04	GRB7, STAP1	SH3/SH2 adaptor activity [MF]
CG_ffipsc197_promoter_p_PM_16_5_12			4	0.8	5.31E-05	QPRT, AGPAT6	water-soluble vitamin metabolic process [BP], quinolinate catabolic process [BP], glandular epithelial cell maturation [BP]
CG_ffipsc197_promoter_p_PM_12_303_13			2	0.4	1.86E-04	SPATA20	mannose-6-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_143_7			2	0.4	1.26E-04	FICD, GPI	protein adenylylation [BP], protein adenylyltransferase activity [MF], methylglyoxal biosynthetic process [BP], glucose-6-phosphate isomerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_102_8			2	0.4	5.44E-05	GPD2, ZFPM1	negative regulation of interleukin-4 biosynthetic process [BP], sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [MF], negative regulation of mast cell differentiation [BP]
CG_ffipsc197_promoter_p_PM_12_159_4			1	0.2	7.11E-05	SLC11A1, GMPS	divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], GMP synthase (glutamine-hydrolyzing) activity [MF], GMP synthase activity [MF], cellular cadmium ion homeostasis [BP], nitrite transport [BP], tertiary granule membrane [CC]
CG_ffipsc197_promoter_p_PM_12_227_11			2	0.4	1.34E-04	ASL	arginine biosynthetic process via ornithine [BP], argininosuccinate lyase activity [MF]
CG_ffipsc197_promoter_p_PM_12_78_6			2	0.4	1.44E-04	NCOA1, GLCE	UDP-glucuronate 5'-epimerase activity [MF], positive regulation of transcription from RNA polymerase II promoter by galactose [BP], heparosan-N-sulfate-glucuronate 5-epimerase activity [MF]
CG_ffipsc197_promoter_p_PM_12_128_16			3	0.6	2.92E-04	DECR2	trans-2-enoyl-CoA reductase (NADPH) activity [MF], 2,4-dienoyl-CoA reductase (NADPH) activity [MF]
CG_ffipsc197_promoter_p_PM_12_24_5			2	0.4	4.50E-05	UBE2V2, TIPRL, HADHB	long-chain-3-hydroxyacyl-CoA dehydrogenase activity [MF], negative regulation of protein phosphatase type 2A activity [BP], mitochondrial fatty acid beta-oxidation multienzyme complex [CC], UBC13-MMS2 complex [CC]
CG_ffipsc197_promoter_p_PM_12_133_5			2	0.4	3.41E-04	IFRD1, ADRA1B	positive regulation of the force of heart contraction by epinephrine-norepinephrine [BP], positive regulation of glycogen catabolic process [BP], myoblast cell fate determination [BP], alpha1-adrenergic receptor activity [MF], adult somatic muscle development [BP], negative regulation of glycogen catabolic process [BP], vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [BP]
CG_ffipsc197_promoter_p_PM_12_306_6			2	0.4	1.06E-04	FDFT1, WRAP53, NOLC1	farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF], Cajal body [CC]
CG_ffipsc197_promoter_p_PM_12_212_7			1	0.2	2.43E-04	REEP2	taste receptor binding [MF], protein transport into membrane raft [BP]
CG_ffipsc197_promoter_p_PM_12_20_6			2	0.4	8.98E-06	SIRT1, COL15A1, BMPR1A	negative regulation of prostaglandin biosynthetic process [BP], collagen type XV [CC], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], neural plate mediolateral regionalization [BP], negative regulation of cAMP-dependent protein kinase activity [BP], paraxial mesoderm structural organization [BP]
CG_ffipsc197_promoter_p_PM_12_47_7			1	0.2	2.09E-05	FNDC1, IL12A, PIPOX, CHAF1A	L-lysine catabolic process to acetyl-CoA via L-pipecolate [BP], DNA replication-dependent nucleosome assembly [BP], positive regulation of cardiac muscle cell apoptotic process [BP], L-pipecolate oxidase activity [MF], interleukin-12 beta subunit binding [MF], interleukin-12 complex [CC], CAF-1 complex [CC], sarcosine oxidase activity [MF], interleukin-27 binding [MF]
CG_ffipsc197_promoter_p_PM_12_112_9			1	0.2	8.54E-05	PIKFYVE	phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [MF], 1-phosphatidylinositol-3-phosphate 5-kinase activity [MF]
CG_ffipsc197_promoter_p_PM_14_55_13			3	0.6	3.55E-05	BYSL, PRKCSH, POR, NMRK2, TET1	regulation of DNA methylation [BP], intracellular [CC], demethylation [BP], negative regulation of lipase activity [BP], intracellular membrane-bounded organelle [CC]
CG_ffipsc197_promoter_p_PM_16_38_28			5	1.0	3.79E-05	SNRPB2, SRSF3, MAP2K6, SNAPC3, VHL, MED15, WBP4, GMNN, CDK9, PIN1, YAP1, TEAD4, NEK6	nucleoplasm [CC], snRNA binding [MF], nuclear speck [CC]
CG_ffipsc197_promoter_p_PM_14_3_9			2	0.4	5.79E-05	BMPR2	regulation of lung blood pressure [BP]
CG_ffipsc197_promoter_p_PM_12_41_11			3	0.6	2.09E-04	GNPAT	glycerone-phosphate O-acyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_14_18_16			4	0.8	2.35E-05	HNMT	histamine N-methyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_22_9			2	0.4	9.98E-05	INHBB, MAPT, CNTNAP1	negative regulation of hepatocyte growth factor biosynthetic process [BP], axon cargo transport [BP], activin receptor signaling pathway [BP], host cell surface receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_237_5			2	0.4	1.10E-04	SRC, NUDT1, BIRC7	cellular response to progesterone stimulus [BP], ATP diphosphatase activity [MF], regulation of natural killer cell apoptotic process [BP]
CG_ffipsc197_promoter_p_PM_16_18_8			3	0.6	2.26E-05	P2RX4, CD4	positive regulation of calcium-mediated signaling [BP]
CG_ffipsc197_promoter_p_PM_12_229_8			3	0.6	2.65E-05	PUS1, SDHA	tRNA pseudouridine synthesis [BP], pseudouridylate synthase activity [MF], succinate dehydrogenase activity [MF], succinate dehydrogenase (ubiquinone) activity [MF]
CG_ffipsc197_promoter_p_PM_14_70_5			2	0.4	9.33E-05	OXT	positive regulation of hindgut contraction [BP], oxytocin receptor binding [MF]
CG_ffipsc197_promoter_p_PM_14_4_13			1	0.2	8.52E-06	PRLH	reduction of food intake in response to dietary excess [BP], prolactin-releasing peptide receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_255_10			2	0.4	1.17E-04	LEP	cellular response to L-ascorbic acid [BP], negative regulation of glutamine transport [BP]
CG_ffipsc197_promoter_p_PM_12_330_13			1	0.2	1.99E-04	IKBKB	IkappaB kinase activity [MF]
CG_ffipsc197_promoter_p_PM_18_1_35			4	0.8	6.85E-05	RAB33B, ISG15	protein tag [MF], regulation of retrograde vesicle-mediated transport, Golgi to ER [BP]
CG_ffipsc197_promoter_p_PM_12_30_7			1	0.2	1.26E-04	PCDHA4, PCDHGA5, PCDHGA11	homophilic cell adhesion [BP]
CG_ffipsc197_promoter_p_PM_12_19_15			3	0.6	1.26E-04	BICD1	regulation of proteinase activated receptor activity [BP], negative regulation of phospholipase C activity [BP], proteinase activated receptor binding [MF], negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], host cell viral assembly compartment [CC]
CG_ffipsc197_promoter_p_PM_12_73_6			3	0.6	2.07E-04	POLA1, CDKN1A, PDE1B	leading strand elongation [BP], cyclin-dependent protein kinase activating kinase activity [MF], calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF]
CG_ffipsc197_promoter_p_PM_14_14_10			3	0.6	4.11E-05	P2RX2, JARID2, RIMS2, EED	purinergic nucleotide receptor activity [MF], detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], presynaptic membrane [CC], ESC/E(Z) complex [CC], histone methyltransferase complex [CC]
CG_ffipsc197_promoter_p_PM_12_326_10			2	0.4	1.11E-04	ST3GAL4, SULT2B1	steroid sulfotransferase activity [MF], sulfate assimilation [BP], alcohol sulfotransferase activity [MF], monosialoganglioside sialyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_88_11			2	0.4	3.02E-05	MCM8, BDKRB2	MCM8-MCM9 complex [CC], bradykinin receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_123_9			1	0.2	2.70E-05	PRNP	negative regulation of calcineurin-NFAT signaling cascade [BP]
CG_ffipsc197_promoter_p_PM_14_54_14			1	0.2	4.61E-05	MACF1, EIF3J, RPS21, RPL27	translational initiation [BP], posttranslational protein targeting to membrane [BP], endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP]
CG_ffipsc197_promoter_p_PM_12_150_10			2	0.4	1.21E-05	JPH3	junctional membrane complex [CC]
CG_ffipsc197_promoter_p_PM_18_20_28			2	0.4	2.83E-05	FKBP1B, CCND1	response to vitamin E [BP]
CG_ffipsc197_promoter_p_PM_12_66_6			1	0.2	3.01E-05	RCAN3, TNNI3K, SH3GLB1, IFNAR2	troponin I binding [MF], lysophosphatidic acid acyltransferase activity [MF], type I interferon receptor activity [MF], type I interferon binding [MF]
CG_ffipsc197_promoter_p_PM_18_29_12			4	0.8	9.47E-05	NDUFS5, THAP6, NDUFAF7	microtubule cytoskeleton [CC], mitochondrial respiratory chain complex I assembly [BP]
CG_ffipsc197_promoter_p_PM_18_2_16			4	0.8	9.16E-05	GTF2F2, COQ7	transcription factor TFIIF complex [CC], age-dependent response to oxidative stress [BP]
CG_ffipsc197_promoter_p_PM_12_162_7			1	0.2	3.24E-05	FAM20C	odontoblast differentiation [BP], dentinogenesis [BP], osteoclast maturation [BP]
CG_ffipsc197_promoter_p_PM_12_253_11			2	0.4	3.85E-05	ATP2A2, ID1, SIRT1	negative regulation of prostaglandin biosynthetic process [BP], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], negative regulation of cAMP-dependent protein kinase activity [BP], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], protein destabilization [BP]
CG_ffipsc197_promoter_p_PM_12_166_11			3	0.6	1.88E-04	MAPK8IP1	dentate gyrus mossy fiber [CC]
CG_ffipsc197_promoter_p_PM_14_40_6			2	0.4	1.85E-05	NLRP2, FAM20B, DHRS2, PSMD3, JAK2, TPM1, PMS1, TAOK2, RPS6KA1	positive regulation of interleukin-1 beta production [BP], mineralocorticoid receptor signaling pathway [BP], histone kinase activity (H3-Y41 specific) [MF], activation of MAPKK activity [BP], histone H3-Y41 phosphorylation [BP], positive regulation of heart rate by epinephrine [BP], apoptotic process [BP], nucleotide binding [MF], activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [BP], ATP binding [MF]
CG_ffipsc197_promoter_p_PM_14_15_19			4	0.8	8.52E-05	SNRPC	U1 snRNP [CC]
CG_ffipsc197_promoter_p_PM_12_3_7			3	0.6	8.68E-05	IL1RL2, TRAT1	cellular defense response [BP]
CG_ffipsc197_promoter_p_PM_12_57_5			2	0.4	1.27E-04	WNT8B	negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway [BP], Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP]
CG_ffipsc197_promoter_p_PM_12_1_6			2	0.4	6.86E-05	ITGAM, ITGBL1, GABRB1	integrin complex [CC], cellular extravasation [BP], receptor complex [CC]
CG_ffipsc197_promoter_p_PM_12_320_7			2	0.4	2.58E-04	NUDT9, KCNAB2, RIPK1	ADP catabolic process [BP], protein heterooligomerization [BP], regulation of ATP:ADP antiporter activity [BP]
CG_ffipsc197_promoter_p_PM_12_181_8			2	0.4	7.20E-05	FSCN1, JAM3, MYO7A	regulation of actin cytoskeleton organization by cell-cell adhesion [BP], actin filament binding [MF]
CG_ffipsc197_promoter_p_PM_12_218_8			2	0.4	2.94E-04	LSM11, DDR2	protein tyrosine kinase collagen receptor activity [MF], U7 snRNA binding [MF], collagen-activated tyrosine kinase receptor signaling pathway [BP], positive regulation of extracellular matrix disassembly [BP]
CG_ffipsc197_promoter_p_PM_16_48_7			6	1.0	5.29E-05	LDLR	low-density lipoprotein particle clearance [BP]
CG_ffipsc197_promoter_p_PM_18_8_26			4	0.8	5.15E-05	STXBP5, SYN2	synaptic vesicle [CC]
CG_ffipsc197_promoter_p_PM_12_64_9			3	0.6	8.23E-05	FZD3, TRH	cell proliferation in midbrain [BP], thyrotropin-releasing hormone activity [MF]
CG_ffipsc197_promoter_p_PM_16_23_16			4	0.8	5.04E-05	CCNB2, SOD1, CUX1	auditory receptor cell differentiation [BP], thymus development [BP], superoxide anion generation [BP]
CG_ffipsc197_promoter_p_PM_12_307_5			3	0.6	9.03E-05	PNPO, NOS3	pyridoxamine-phosphate oxidase activity [MF], FMN binding [MF]
CG_ffipsc197_promoter_p_PM_14_42_6			2	1.0	5.77E-05	MIF, MARCKS	positive regulation of prostaglandin secretion involved in immune response [BP], germinal vesicle [CC]
CG_ffipsc197_promoter_p_PM_12_36_6			2	0.4	6.78E-05	FOXN1, AIP, CRIP1	GAF domain binding [MF], DNA binding, bending [MF]
CG_ffipsc197_promoter_p_PM_18_30_33			3	0.6	7.25E-05	LRP1, LZTR1, CASP8, GRHPR	Noc1p-Noc2p complex [CC], anatomical structure morphogenesis [BP], lipoprotein transporter activity [MF], glyoxylate reductase (NADP) activity [MF], glycerate dehydrogenase activity [MF], negative regulation of platelet-derived growth factor receptor-beta signaling pathway [BP], hydroxypyruvate reductase activity [MF]
CG_ffipsc197_promoter_p_PM_12_2_10			3	0.6	1.56E-04	DRD4, CTNNA1, GALM, APC	aldose 1-epimerase activity [MF], gamma-catenin binding [MF], cell-cell adherens junction [CC], olfactory learning [BP], apical junction assembly [BP]
CG_ffipsc197_promoter_p_PM_12_76_9			2	0.4	2.33E-05	ADRA2C, ALB	activation of MAPK activity by adrenergic receptor signaling pathway [BP], response to platinum ion [BP], alpha2-adrenergic receptor activity [MF], hemolysis by symbiont of host erythrocytes [BP], maintenance of mitochondrion location [BP], positive regulation of circadian sleep/wake cycle, non-REM sleep [BP], negative regulation of uterine smooth muscle contraction [BP]
CG_ffipsc197_promoter_p_PM_12_260_12			4	0.8	5.74E-05	FTL, CDC5L	WD40-repeat domain binding [MF], intracellular ferritin complex [CC]
CG_ffipsc197_promoter_p_PM_12_7_8			3	0.6	4.23E-04	ZNF793, ZNF700, ZNF233, CNOT6, ZNF555, PDXK, GLI4, ZNF586, ZKSCAN8, ZNF623, ZNF549, ZSCAN21, ZNF763, SLC35F6	DNA binding [MF], metal ion binding [MF], zinc ion binding [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], gene expression [BP], RNA metabolic process [BP], nucleus [CC]
CG_ffipsc197_promoter_p_PM_12_323_12			3	0.6	1.04E-04	RHOQ, GNPAT, GRHPR	glyoxylate reductase (NADP) activity [MF], peroxisomal matrix [CC], GBD domain binding [MF], glycerate dehydrogenase activity [MF], hydroxypyruvate reductase activity [MF], glycerone-phosphate O-acyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_235_11			3	0.6	2.13E-04	AR, HEXB	POU domain binding [MF], male somatic sex determination [BP], male courtship behavior [BP], negative regulation of integrin biosynthetic process [BP], activation of prostate induction by androgen receptor signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_185_8			3	0.6	9.51E-05	ABHD10, CLEC3B	glucuronoside catabolic process [BP], kringle domain binding [MF]
CG_ffipsc197_promoter_p_PM_12_295_13			1	0.2	2.54E-05	SAG	opsin binding [MF]
CG_ffipsc197_promoter_p_PM_12_239_8			3	0.6	6.10E-05	COL14A1, GALM, DNM1L	aldose 1-epimerase activity [MF], collagen type XIV [CC], dynamin polymerization involved in mitochondrial fission [BP], membrane fission involved in mitochondrial fission [BP]
CG_ffipsc197_promoter_p_PM_12_27_11			3	0.6	1.22E-05	EXOSC9, CSF3, UTS2R	positive regulation of cell growth [BP], nuclear polyadenylation-dependent rRNA catabolic process [BP], urotensin II receptor activity [MF], granulocyte colony-stimulating factor receptor binding [MF]
CG_ffipsc197_promoter_p_PM_18_11_44			4	0.8	5.43E-05	SPAST, CMYA5, MAP2K1, STARD9, TPD52L2, RASA2, ITPR3, FKBP1B, TUBGCP5, MAPRE3, EHD2	intracellular ligand-gated calcium channel activity [MF], negative regulation of protein phosphatase type 2B activity [BP], microtubule binding [MF], perinuclear region of cytoplasm [CC]
CG_ffipsc197_promoter_p_PM_12_321_11			2	0.4	1.32E-04	TLR3, AZU1, MTNR1B	positive regulation of fractalkine biosynthetic process [BP], positive regulation of interleukin-1 beta biosynthetic process [BP], positive regulation of chemokine biosynthetic process [BP], cellular extravasation [BP], defense response to bacterium [BP], melatonin receptor activity [MF], positive regulation of type III interferon production [BP], detection of virus [BP]
CG_ffipsc197_promoter_p_PM_12_314_4			1	0.2	5.30E-05	MICB, MICA, AKR1C3, DPEP1	natural killer cell lectin-like receptor binding [MF], antigen processing and presentation [BP], ketoreductase activity [MF], prostaglandin D2 11-ketoreductase activity [MF], regulation of retinoic acid receptor signaling pathway [BP], modified amino acid binding [MF], prostaglandin-F synthase activity [MF], MHC class I protein complex [CC], cellular response to calcium ion [BP], cellular lactam catabolic process [BP], gamma-delta T cell activation [BP], 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [MF], cytolysis [BP], negative regulation of retinoic acid biosynthetic process [BP], dihydrotestosterone 17-beta-dehydrogenase activity [MF]
CG_ffipsc197_promoter_p_PM_16_4_11			3	0.6	2.57E-05	AGTRAP	cytoplasmic vesicle membrane [CC]
CG_ffipsc197_promoter_p_PM_16_21_23			5	1.0	5.00E-05	ARFGEF2, DPPA3	symmetric synapse [CC], negative regulation of DNA demethylation [BP], protection of DNA demethylation of female pronucleus [BP]
CG_ffipsc197_promoter_p_PM_12_74_7			2	0.4	3.95E-05	SNX22, PSTPIP1, DNM1, NCF4, PKN1	phospholipid binding [MF], cleavage furrow [CC], phosphatidylinositol binding [MF]
CG_ffipsc197_promoter_p_PM_12_34_5			2	0.4	4.80E-05	PARK7, INHBB	positive regulation of oxidative phosphorylation uncoupler activity [BP], negative regulation of hepatocyte growth factor biosynthetic process [BP], oocyte development [BP], host cell surface receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_40_10			2	0.4	4.21E-05	PANX1	leak channel activity [MF], positive regulation of interleukin-1 alpha secretion [BP]
CG_ffipsc197_promoter_p_PM_12_213_8			2	0.4	2.34E-05	SLC25A42, SLC30A7, SLC28A2	ADP transmembrane transporter activity [MF], ADP transport [BP], purine nucleoside transmembrane transport [BP], nucleoside:sodium symporter activity [MF], ATP transmembrane transporter activity [MF], coenzyme A transmembrane transporter activity [MF], adenosine-diphosphatase activity [MF], transmembrane transport [BP], AMP transmembrane transporter activity [MF], coenzyme A transmembrane transport [BP], purine nucleoside transmembrane transporter activity [MF], ATP transport [BP], AMP transport [BP]
CG_ffipsc197_promoter_p_PM_12_29_10			4	0.6	7.17E-05	GTPBP4, AACS	negative regulation of collagen binding [BP], acetoacetate-CoA ligase activity [MF]
CG_ffipsc197_promoter_p_PM_12_49_5			2	0.4	1.73E-04	HAO2, CYP2F1, TP63, SPHK2	ectoderm and mesoderm interaction [BP], naphthalene metabolic process [BP], mandelate metabolic process [BP], sphinganine-1-phosphate biosynthetic process [BP], trichloroethylene metabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_56_10			4	0.6	9.28E-05	PPIF, MTR	methionine synthase activity [MF], regulation of proton-transporting ATPase activity, rotational mechanism [BP]
CG_ffipsc197_promoter_p_PM_12_136_7			4	0.8	3.68E-05	PPP2R4, SPHK1	sphingoid catabolic process [BP], protein phosphatase 2A binding [MF], calcium channel complex [CC]
CG_ffipsc197_promoter_p_PM_12_116_9			3	0.6	1.66E-04	LAT2, MCF2L, CAPN11, CAPN10, DNAJB13, PSMC1, IL1RL1, ATCAY	negative regulation of glutamate metabolic process [BP], calcium-dependent cysteine-type endopeptidase activity [MF], interleukin-33 receptor activity [MF], intracellular signal transduction [BP], apoptotic process [BP], interleukin-33 binding [MF]
CG_ffipsc197_promoter_p_PM_14_39_11			2	0.4	1.03E-04	ACO2, IDH3A	tricarboxylic acid cycle [BP]
CG_ffipsc197_promoter_p_PM_12_189_7			3	0.6	1.63E-05	UCHL1, PFKM	6-phosphofructokinase complex [CC], axon target recognition [BP], 6-phosphofructokinase activity [MF]
CG_ffipsc197_promoter_p_PM_12_21_5			2	0.4	4.57E-04	SH2B2, LANCL2	JAK pathway signal transduction adaptor activity [MF], positive regulation of abscisic acid mediated signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_72_9			1	0.2	3.44E-05	DYNAP, JMY, GRK1, ADRA2C	activation of protein kinase B activity [BP], regulation of rhodopsin mediated signaling pathway [BP], 'de novo' actin filament nucleation [BP], cellular response to ergosterol [BP]
CG_ffipsc197_promoter_p_PM_12_175_5			5	1.0	1.70E-04	MERTK, PCK1	rhabdomere [CC], glycerol biosynthetic process from pyruvate [BP]
CG_ffipsc197_promoter_p_PM_12_302_6			2	0.4	2.10E-05	CLIC6	D4 dopamine receptor binding [MF], D3 dopamine receptor binding [MF], D2 dopamine receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_137_6			2	0.4	1.25E-04	MUC5B	extracellular matrix structural constituent [MF]
CG_ffipsc197_promoter_p_PM_12_241_7			2	0.4	9.04E-05	CACNG4, DIO3, B3GALT6	voltage-gated calcium channel complex [CC], thyroxine 5-deiodinase activity [MF], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_67_14			2	0.4	1.50E-04	PAPD4, CD1C	endogenous lipid antigen binding [MF], nuclear RNA-directed RNA polymerase complex [CC]
CG_ffipsc197_promoter_p_PM_16_41_19			3	0.6	1.36E-05	METAP1D	peptidyl-methionine modification [BP]
CG_ffipsc197_promoter_p_PM_12_246_5			3	0.6	2.12E-04	TRHR, PCSK2	insulin processing [BP], enkephalin processing [BP], thyrotropin-releasing hormone receptor activity [MF], islet amyloid polypeptide processing [BP]
CG_ffipsc197_promoter_p_PM_12_144_10			2	0.4	1.50E-05	CARKD, CNDP1	ATP-dependent NAD(P)H-hydrate dehydratase activity [MF], tripeptidase activity [MF]
CG_ffipsc197_promoter_p_PM_14_9_34			7	1.0	7.63E-05	INPPL1, RRP36, JARID2, ZP3, KHDRBS1, KAT5, RPS28, SPEN, CDK5R1, NACC1, BTAF1, ILF3, CDC42, EHMT1	negative regulation of gene expression [BP], negative regulation of transcription, DNA-dependent [BP], ribosomal small subunit biogenesis [BP]
CG_ffipsc197_promoter_p_PM_18_13_15			3	0.6	6.10E-05	BRCA2	cell aging [BP], regulation of S phase of mitotic cell cycle [BP]
CG_ffipsc197_promoter_p_PM_12_110_6			3	0.6	2.99E-05	CARM1, YWHAH	negative regulation of dendrite morphogenesis [BP], histone methyltransferase activity (H3-R17 specific) [MF], histone H3-R17 methylation [BP], regulation of growth plate cartilage chondrocyte proliferation [BP], glucocorticoid catabolic process [BP], histone H3-R2 methylation [BP], pathogenesis [BP]
CG_ffipsc197_promoter_p_PM_12_53_18			1	0.2	4.45E-05	IDO2, KMO	kynurenine metabolic process [BP], tryptophan catabolic process to kynurenine [BP], tryptophan catabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_177_10			4	0.8	1.64E-04	POLI, NEIL2, SLC30A9	damaged DNA binding [MF], DNA repair [BP], nucleotide-excision repair [BP]
CG_ffipsc197_promoter_p_PM_12_309_6			3	0.6	2.10E-05	TGS1, SIRT1	7-methylguanosine cap hypermethylation [BP], peptidyl-lysine deacetylation [BP], triglyceride mobilization [BP], negative regulation of cAMP-dependent protein kinase activity [BP], RNA trimethylguanosine synthase activity [MF], pyrimidine dimer repair by nucleotide-excision repair [BP], ribonucleoprotein complex import into nucleus [BP], regulation of bile acid biosynthetic process [BP], positive regulation of macrophage apoptotic process [BP], regulation of endodeoxyribonuclease activity [BP], negative regulation of cellular response to testosterone stimulus [BP], positive regulation of insulin receptor signaling pathway [BP], ribonucleoprotein complex biogenesis [BP], cellular triglyceride homeostasis [BP], ncRNA metabolic process [BP], positive regulation of cellular senescence [BP], HLH domain binding [MF], regulation of peroxisome proliferator activated receptor signaling pathway [BP], negative regulation of helicase activity [BP], negative regulation of prostaglandin biosynthetic process [BP], negative regulation of cellular senescence [BP], maintenance of chromatin silencing [BP], establishment of chromatin silencing [BP], single strand break repair [BP], positive regulation of MHC class II biosynthetic process [BP], positive regulation of chromatin silencing [BP], positive regulation of cAMP-dependent protein kinase activity [BP]
CG_ffipsc197_promoter_p_PM_12_300_6			4	0.8	6.24E-05	DRD5, BIRC5	interphase microtubule organizing center [CC], sensitization [BP], negative regulation of NAD(P)H oxidase activity [BP], dopamine neurotransmitter receptor activity, coupled via Gs [MF]
CG_ffipsc197_promoter_p_PM_12_202_7			4	0.8	1.87E-04	PCK1	phosphoenolpyruvate carboxykinase (GTP) activity [MF], glycerol biosynthetic process from pyruvate [BP]
CG_ffipsc197_promoter_p_PM_12_54_11			4	0.8	7.72E-05	SMYD2, CDC73, AGTR1	angiotensin type I receptor activity [MF], acetyltransferase activator activity [MF], bradykinin receptor binding [MF], RNA polymerase II core binding [MF], phospholipase C-activating angiotensin-mediated signaling pathway [BP], positive regulation of NAD(P)H oxidase activity [BP]
CG_ffipsc197_promoter_p_PM_12_39_7			2	0.4	1.01E-04	RBPJ	recombinase activity [MF], blood vessel endothelial cell fate specification [BP], positive regulation of ephrin receptor signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_105_11			3	0.6	1.43E-04	GRK1	regulation of rhodopsin mediated signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_289_7			1	0.2	8.17E-05	DNAAF1, CACNA1D, IVD	isovaleryl-CoA dehydrogenase activity [MF], regulation of cilium beat frequency [BP], membrane repolarization involved in regulation of SA node cell action potential [BP], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF]
CG_ffipsc197_promoter_p_PM_12_251_6			2	0.4	2.22E-04	ABCD1	peroxisomal long-chain fatty acid import [BP], peroxisomal fatty-acyl-CoA transporter activity [MF]
CG_ffipsc197_promoter_p_PM_12_25_9			4	0.8	1.83E-04	LDHC	lactate oxidation [BP]
CG_ffipsc197_promoter_p_PM_14_72_13			12	1.0	5.87E-05	DCLRE1B, FKBP4	telomeric loop formation [BP], telomeric 3' overhang formation [BP], steroid hormone receptor complex assembly [BP]
CG_ffipsc197_promoter_p_PM_12_257_9			3	0.6	4.26E-05	IGHMBP2	DNA duplex unwinding [BP], ATP-dependent 5'-3' RNA helicase activity [MF]
CG_ffipsc197_promoter_p_PM_12_186_15			2	0.4	2.46E-04	PRMT7	[myelin basic protein]-arginine N-methyltransferase activity [MF], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP], histone methyltransferase activity (H4-R3 specific) [MF], peptidyl-arginine omega-N-methylation [BP], protein-arginine omega-N monomethyltransferase activity [MF], protein-arginine omega-N symmetric methyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_12_297_9			3	0.6	1.19E-04	ACADS, POLR1B	butyrate catabolic process [BP], butyryl-CoA dehydrogenase activity [MF], nucleologenesis [BP]
CG_ffipsc197_promoter_p_PM_18_14_39			4	0.8	2.21E-05	P2RX4, CD4	positive regulation of calcium-mediated signaling [BP]
CG_ffipsc197_promoter_p_PM_12_48_8			2	0.4	1.30E-04	GPC1, IDO2	heparan sulfate proteoglycan catabolic process [BP], indoleamine 2,3-dioxygenase activity [MF]
CG_ffipsc197_promoter_p_PM_14_60_8			1	0.2	4.19E-05	SDHAF2, BTRC, IFT88, MRI1, NUDT7	positive regulation of proteolysis [BP], S-methyl-5-thioribose-1-phosphate isomerase activity [MF], protein-FAD linkage [BP], L-methionine biosynthetic process from S-adenosylmethionine [BP], smoothened signaling pathway [BP], acetyl-CoA catabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_23_10			2	0.4	2.65E-05	B2M	early endosome lumen [CC], antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [BP]
CG_ffipsc197_promoter_p_PM_14_25_9			5	0.8	9.89E-06	TCF7, SOX17, CDKN1A	PCNA-p21 complex [CC], cardiogenic plate morphogenesis [BP], endodermal cell fate determination [BP], regulation of stem cell division [BP], inner cell mass cellular morphogenesis [BP], beta-catenin binding [MF], stem cell fate specification [BP], cyclin-dependent protein kinase activating kinase activity [MF], regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP]
CG_ffipsc197_promoter_p_PM_14_41_6			1	0.2	2.47E-05	NUDT1, HRG, RALB, FKBP4	negative regulation of lamellipodium assembly [BP], ATP diphosphatase activity [MF], DNA protection [BP], protein complex localization [BP], dGTP catabolic process [BP], positive regulation of blood vessel remodeling [BP], steroid hormone receptor complex assembly [BP], negative regulation of vascular endothelial growth factor signaling pathway [BP], regulation of exocyst assembly [BP], negative regulation of endothelial cell chemotaxis [BP], regulation of protein complex assembly [BP]
CG_ffipsc197_promoter_p_PM_12_18_6			1	0.2	2.64E-05	OXA1L	mitochondrial proton-transporting ATP synthase complex assembly [BP], mitochondrial ribosome binding [MF]
CG_ffipsc197_promoter_p_PM_12_101_13			2	0.4	2.79E-04	HHEX	repressing transcription factor binding [MF], hepatic duct development [BP]
CG_ffipsc197_promoter_p_PM_14_73_13			12	1.0	3.70E-05	FURIN	negative regulation of low-density lipoprotein particle receptor catabolic process [BP]
CG_ffipsc197_promoter_p_PM_14_30_17			3	0.4	4.79E-05	PDXK	lithium ion binding [MF], pyridoxal phosphate biosynthetic process [BP], vitamin B6 metabolic process [BP], pyridoxal 5'-phosphate salvage [BP], pyridoxal kinase activity [MF]
CG_ffipsc197_promoter_p_PM_14_66_7			2	0.4	8.25E-05	TGS1	ribonucleoprotein complex import into nucleus [BP], RNA trimethylguanosine synthase activity [MF], 7-methylguanosine cap hypermethylation [BP]
CG_ffipsc197_promoter_p_PM_12_81_9			2	0.4	8.57E-05	CHST14, NCAN	dermatan sulfate proteoglycan metabolic process [BP], dermatan sulfate biosynthetic process [BP]
CG_ffipsc197_promoter_p_PM_12_77_10			3	0.6	1.90E-05	TNNI2	troponin T binding [MF]
CG_ffipsc197_promoter_p_PM_16_28_12			1	0.2	8.73E-05	PPP5C, STX3, RPS6KB1, PNPLA3	mono-olein transacylation activity [MF], response to electrical stimulus involved in regulation of muscle adaptation [BP], neuron projection [CC], diolein transacylation activity [MF]
CG_ffipsc197_promoter_p_PM_14_68_24			4	0.6	5.42E-05	PRSS3, MMP11, MMP9, MMP14	collagen catabolic process [BP], zymogen activation [BP], extracellular matrix disassembly [BP], metalloendopeptidase activity [MF]
CG_ffipsc197_promoter_p_PM_12_31_7			3	0.6	2.54E-05	UBE2E2, RNF4	protein K63-linked ubiquitination [BP], protein K11-linked ubiquitination [BP], protein K48-linked ubiquitination [BP], regulation of kinetochore assembly [BP], progesterone receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_169_4			1	0.2	6.05E-05	NUDT9, SLC1A3, FXN, PPYR1, OXT	positive regulation of hindgut contraction [BP], high-affinity glutamate transmembrane transporter activity [MF], iron chaperone activity [MF], gamma-aminobutyric acid biosynthetic process [BP], regulation of ferrochelatase activity [BP], feeding behavior [BP], ADP catabolic process [BP], positive regulation of female receptivity [BP], positive regulation of synaptic transmission [BP], IDP catabolic process [BP], oxytocin receptor binding [MF], positive regulation of norepinephrine secretion [BP], iron incorporation into metallo-sulfur cluster [BP]
CG_ffipsc197_promoter_p_PM_12_121_4			1	0.2	8.84E-05	RHO	photoreceptor inner segment membrane [CC], red, far-red light phototransduction [BP]
CG_ffipsc197_promoter_p_PM_12_42_5			3	0.6	2.85E-04	MGMT	methylated-DNA-[protein]-cysteine S-methyltransferase activity [MF]
CG_ffipsc197_promoter_p_PM_14_59_6			2	0.4	1.24E-04	CDC5L, SLC35A3, SHBG	UDP-N-acetylglucosamine transmembrane transporter activity [MF], WD40-repeat domain binding [MF], UDP-N-acetylglucosamine transport [BP], primary spermatocyte growth [BP]
CG_ffipsc197_promoter_p_PM_14_11_11			10	1.0	4.89E-05	TGFBR2, MSH2, F2RL1, CDC42EP1, BPTF	embryonic placenta development [BP], positive regulation of pseudopodium assembly [BP], in utero embryonic development [BP]
CG_ffipsc197_promoter_p_PM_14_43_9			3	0.6	1.82E-04	PALM	D3 dopamine receptor binding [MF]
CG_ffipsc197_promoter_p_PM_12_87_9			3	0.6	1.16E-04	SERPINE1, DYNLL2, ZNF205	positive regulation of hydrogen peroxide biosynthetic process [BP], synaptic target recognition [BP], negative regulation of vascular wound healing [BP], positive regulation of leukotriene production involved in inflammatory response [BP], positive regulation of mitochondrial outer membrane permeabilization [BP]
CG_ffipsc197_promoter_p_PM_12_26_10			3	0.6	1.21E-04	CCNE1, CD2AP, CCNF	cyclin-dependent protein kinase holoenzyme complex [CC], cell division [BP]
CG_ffipsc197_promoter_p_PM_12_198_12			1	0.2	2.34E-04	IL6R, DUSP19	interleukin-6 receptor complex [CC], interleukin-6 binding [MF], hepatic immune response [BP], JUN kinase phosphatase activity [MF], negative regulation of collagen biosynthetic process [BP], ciliary neurotrophic factor binding [MF], interleukin-6 receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_126_10			2	0.4	1.71E-04	SSH3, SLC12A3, CDKN3	protein tyrosine/serine/threonine phosphatase activity [MF], sodium:chloride symporter activity [MF]
CG_ffipsc197_promoter_p_PM_16_31_8			5	1.0	1.55E-05	PEX13, FKBP1B, ASXL1	microtubule-based peroxisome localization [BP], negative regulation of release of sequestered calcium ion into cytosol [BP], monoubiquitinated histone H2A deubiquitination [BP], positive regulation of sequestering of calcium ion [BP], negative regulation of peroxisome proliferator activated receptor signaling pathway [BP]
CG_ffipsc197_promoter_p_PM_12_277_20			4	0.8	2.61E-04	CABYR	sperm fibrous sheath [CC]
CG_ffipsc197_promoter_p_PM_14_45_6			1	0.2	2.72E-04	SOX9	positive regulation of mesenchymal stem cell differentiation [BP], renal vesicle induction [BP], male germ-line sex determination [BP], intrahepatic bile duct development [BP], regulation of cell proliferation involved in tissue homeostasis [BP], ureter urothelium development [BP], retinal rod cell differentiation [BP], epithelial cell proliferation involved in prostatic bud elongation [BP], chondrocyte hypertrophy [BP]
CG_ffipsc197_promoter_p_PM_12_305_11			2	0.4	1.63E-04	HCN2, PNMT, ASIC4	sodium ion transmembrane transporter activity [MF], phenylethanolamine N-methyltransferase activity [MF], epinephrine biosynthetic process [BP], sodium channel activity [MF]
CG_ffipsc197_promoter_p_PM_12_325_8			2	0.4	4.56E-05	PRPF31, LGALS9, SWI5	U4 snRNP [CC], U2-type spliceosomal complex [CC], Swi5-Sfr1 complex [CC], snRNP binding [MF], U4atac snRNP [CC], U4/U6 x U5 tri-snRNP complex [CC], galactose binding [MF]
CG_ffipsc197_promoter_p_PM_12_259_7			1	0.2	7.30E-05	AFMID, FUT8, PRLH	N-glycan fucosylation [BP], arylformamidase activity [MF], glycoprotein 6-alpha-L-fucosyltransferase activity [MF], prolactin-releasing peptide receptor binding [MF]
CG_ffipsc197_promoter_p_PM_18_21_25			3	0.6	9.30E-05	OGDH	oxoglutarate dehydrogenase complex [CC], oxoglutarate dehydrogenase (NAD+) activity [MF], olfactory bulb mitral cell layer development [BP]
CG_ffipsc197_promoter_p_PM_12_252_5			1	0.2	7.38E-05	AHCYL1	adenosylhomocysteinase activity [MF]
CG_ffipsc197_promoter_p_PM_18_23_15			1	0.2	3.75E-05	JMY, XPOT, SMCHD1, AGBL5	protein branching point deglutamylation [BP], 'de novo' actin filament nucleation [BP], tRNA export from nucleus [BP], inactivation of X chromosome by DNA methylation [BP]
CG_ffipsc197_promoter_p_PM_12_276_10			3	0.6	7.35E-05	NPM1, PLCG2	follicular B cell differentiation [BP], regulation of endoribonuclease activity [BP]
CG_ffipsc197_promoter_p_PM_18_16_24			4	0.8	3.85E-05	RAC1, DLAT, BCR, ALDH5A1, CYTH2, CDKAL1, AGL	actin cytoskeleton organization [BP], RNA modification [BP], glucose metabolic process [BP]
CG_ffipsc197_promoter_p_PM_12_299_9			2	0.4	6.42E-05	ACADM, CYSLTR2	medium-chain fatty acid catabolic process [BP], cysteinyl leukotriene receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_284_9			3	0.6	2.33E-05	DIO3, FSTL3	neuron projection terminus [CC], thyroxine 5-deiodinase activity [MF]
CG_ffipsc197_promoter_p_PM_16_10_21			2	0.4	5.78E-05	FXN, ASIC1, MGAT2	regulation of ferrochelatase activity [BP], response to pH [BP], alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], iron chaperone activity [MF]
CG_ffipsc197_promoter_p_PM_12_268_8			3	0.6	4.67E-06	MC1R	melanocyte-stimulating hormone receptor activity [MF]
CG_ffipsc197_promoter_p_PM_12_283_6			3	0.6	3.74E-05	STK11, KCNAB2, ARID1A	nucleosome mobilization [BP], protein heterooligomerization [BP]
CG_ffipsc197_promoter_p_PM_12_173_7			2	0.4	1.63E-04	MALSU1, BCKDK, ACADS	butyrate catabolic process [BP], negative regulation of mitochondrial translation [BP], mitochondrial matrix [CC], butyryl-CoA dehydrogenase activity [MF], [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [MF]
CG_ffipsc197_promoter_p_PM_12_152_5			2	0.4	1.10E-04	AFMID, IL13RA1	interleukin-13 receptor complex [CC], arylformamidase activity [MF]